Meet Harriet and Isiah, 2 patients who have been or will be diagnosed with PAD. Is XARELTO®, in combination with aspirin, a management option for them? Find out with this simulation that reviews key clinical considerations for the use of XARELTO®, in combination with aspirin, in patients with PAD.
This promotional educational activity is brought to you by Janssen Pharmaceuticals, Inc., and is not certified for continuing medical education. The consultant is a paid speaker for Janssen Pharmaceuticals, Inc. The speaker is presenting on behalf of Janssen and must present information in compliance with FDA requirements applicable to Janssen.
© Janssen Pharmaceuticals, Inc. 2022 07/22 cp-275243v1